論文 - 黒瀬 顕
-
Destroyed lung due to sustained inflammation after chemoradiotherapy followed by durvalumab.
Kageaki Taima, Hisashi Tanaka, Masamichi Itoga, Yoshiko Ishioka, Akira Kurose, Sadatomo Tasaka
Respirology case reports 8 ( 5 ) e00580 - e00580 2020年07月
-
Destroyed lung due to sustained inflammation after chemoradiotherapy followed by durvalumab.
Taima K, Tanaka H, Itoga M, Ishioka Y, Kurose A, Tasaka S
Respirology case reports 8 ( 5 ) e00580 2020年07月
-
Teriparatide may accelerate the growth of a pre-existing malignant tumor in an elderly patient with osteoporosis: A case report.
Ogawa T, Ohshika S, Yanagisawa M, Kurose A, Ishibashi Y
Mol Clin Oncol 2020年02月
-
Teriparatide may accelerate the growth of a pre-existing malignant tumor in an elderly patient with osteoporosis: A case report.
Ogawa T, Ohshika S, Yanagisawa M, Kurose A, Ishibashi Y
Molecular and clinical oncology 12 ( 2 ) 144 - 147 2020年02月
-
Giant cell glioblastoma is a distinctive subtype of glioma characterized by vulnerability to DNA damage
Ogawa K, Kurose A, Kamataki A, Asano K, Katayama K, Kurotaki H
Brain Tumor Pathol 2020年01月
-
Giant cell glioblastoma is a distinctive subtype of glioma characterized by vulnerability to DNA damage.
Ogawa K, Kurose A, Kamataki A, Asano K, Katayama K, Kurotaki H
Brain tumor pathology 37 ( 1 ) 5 - 13 2020年01月
-
胸水細胞診で診断しえたALK陽性未分化大細胞型リンパ腫の1例
小林弘実，小島啓子，熊谷直哉，川村麻緒，岡田壮士，藤田大貴，小田嶋広和，板橋智映子，工藤和洋，高畑武功，加藤哲子，黒瀬顕
青森県臨床細胞学会雑誌 2020年
-
Toll-Like Receptor 3 as a Recurrence Risk Factor and a Potential Molecular Therapeutic Target in Colorectal Cancer.
Tatsuya Yoshida, Takuya Miura, Tomoh Matsumiya, Hidemi Yoshida, Hajime Morohashi, Yoshiyuki Sakamoto, Akira Kurose, Tadaatsu Imaizumi, Kenichi Hakamada
Clinical and experimental gastroenterology 13 427 - 438 2020年
-
27年前の卵巣漿液性境界悪性腫瘍の再発と考えられた胸壁腫瘍
熊谷直哉，加藤哲子，黒滝日出一，木村大輔，二神真行，鎌滝章央，黒瀬顕
診断病理 37 ( 2 ) 142 - 146 2020年
-
頭蓋内転移をきたし, 開頭手術とガンマナイフを組み合わせて治療した明細胞性髄膜腫の1例
佐々木 貴夫, 浅野 研一郎, 角田 聖英, 片山 耕輔, 大熊 洋揮, 黒瀬 顕
脳神経外科ジャーナル 29 ( 10 ) 718 - 725 2020年
-
Toll-Like Receptor 3 as a Recurrence Risk Factor and a Potential Molecular Therapeutic Target in Colorectal Cancer.
Yoshida T, Miura T, Matsumiya T, Yoshida H, Morohashi H, Sakamoto Y, Kurose A, Imaizumi T, Hakamada K
Clinical and experimental gastroenterology 13 427 - 438 2020年
-
臨床医のための神経病理再入門，髄膜腫
黒瀬顕，小川薫
Clinical Neuroscience 2019年12月
-
臨床医のための神経病理再入門，神経線維腫
黒瀬顕，小川薫
Clinical Neuroscience 2019年11月
-
A Long Interval from a Spinal Cord Lesion to a Subsequent Brain Lesion in Primary Central Nervous System Vasculitis.
Kon T, Funamizu Y, Suzuki C, Sato T, Kurotaki H, Kurihara A, Kurose A, Wakabayashi K, Tomiyama M
Internal medicine (Tokyo, Japan) 58 ( 10 ) 1485 - 1489 2019年05月
-
PIK3CA hotspot mutations and cyclooxygenase-2 expression in ovarian clear cell carcinomas: a close association with stromal features.
Kato N, Sato Y, Kamataki A, Fukase M, Uchigasaki S, Kurose A
Human pathology 86 32 - 37 2019年04月
-
病理医育成の新時代
黒瀬顕
病理と臨床 37 ( 1 ) 27 - 29 2019年01月
-
捺印細胞診が診断に有用であった骨表在性Ewing肉腫の1例
岡田壮士，加藤哲子，大鹿周佐，鎌滝章央，黒瀬顕
日本臨床細胞学会雑誌 58 ( 4 ) 178 - 179 2019年
-
捺印細胞診が診断に有用であった骨表在性 Ewing 肉腫の 1 例
岡田 壮士, 加藤 哲子, 大鹿 周佐, 鎌滝 章央, 黒瀬 顕
日本臨床細胞学会雑誌 58 ( 4 ) 178 - 179 2019年
-
Two siblings with familial neuroblastoma with distinct clinical phenotypes harboring an ALK germline mutation.
Ko Kudo, Hiroo Ueno, Tomohiko Sato, Kaori Kubo, Rika Kanezaki, Akie Kobayashi, Takuya Kamio, Shinya Sasaki, Kiminori Terui, Akira Kurose, Kenichi Yoshida, Yusuke Shiozawa, Tsutomu Toki, Seishi Ogawa, Etsuro Ito
Genes, chromosomes & cancer 57 ( 12 ) 665 - 669 2018年12月
-
PIK3CA hotspot mutations and cyclooxygenase-2 expression in ovarian clear cell carcinomas: a close association with stromal features.
Noriko Kato, Yuka Sato, Akihisa Kamataki, Masayuki Fukase, Shinya Uchigasaki, Akira Kurose
Human pathology 2018年11月